These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1107 related articles for article (PubMed ID: 34737318)

  • 1. Distinct SARS-CoV-2 antibody reactivity patterns elicited by natural infection and mRNA vaccination.
    Assis R; Jain A; Nakajima R; Jasinskas A; Khan S; Palma A; Parker DM; Chau A; ; Obiero JM; Tifrea D; Leung A; Grabar C; Muqolli F; Khalil G; Escobar JC; Ventura J; Davies DH; Albala B; Boden-Albala B; Schubl S; Felgner PL
    NPJ Vaccines; 2021 Nov; 6(1):132. PubMed ID: 34737318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Serological Analysis of the Humoral Immune Responses of Anti-RBD IgG, Anti-S1 IgG, and Anti-S2 IgG Levels Correlated to Anti-N IgG Positivity and Negativity in Sicilian Healthcare Workers (HCWs) with Third Doses of the mRNA-Based SARS-CoV-2 Vaccine: A Retrospective Cohort Study.
    Serra N; Andriolo M; Butera I; Mazzola G; Sergi CM; Fasciana TMA; Giammanco A; Gagliano MC; Cascio A; Di Carlo P
    Vaccines (Basel); 2023 Jun; 11(7):. PubMed ID: 37514952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine Learning Classification of Time since BNT162b2 COVID-19 Vaccination Based on Array-Measured Antibody Activity.
    Ma QL; Huang FM; Guo W; Feng KY; Huang T; Cai YD
    Life (Basel); 2023 May; 13(6):. PubMed ID: 37374086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients.
    Trougakos IP; Terpos E; Zirou C; Sklirou AD; Apostolakou F; Gumeni S; Charitaki I; Papanagnou ED; Bagratuni T; Liacos CI; Scorilas A; Korompoki E; Papassotiriou I; Kastritis E; Dimopoulos MA
    BMC Med; 2021 Aug; 19(1):208. PubMed ID: 34420521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to NCP, RBD and S2 SARS-CoV-2 in Vaccinated and Unvaccinated Healthcare Workers.
    Błaszczuk A; Michalski A; Malm M; Drop B; Polz-Dacewicz M
    Vaccines (Basel); 2022 Jul; 10(8):. PubMed ID: 35893818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low SARS-CoV-2 infection rates and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic.
    Brehm TT; Thompson M; Ullrich F; Schwinge D; Addo MM; Spier A; Knobloch JK; Aepfelbacher M; Lohse AW; Lütgehetmann M; Schulze Zur Wiesch J
    Int J Hyg Environ Health; 2021 Sep; 238():113851. PubMed ID: 34601375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired SARS-CoV-2-specific T-cell reactivity in patients with cirrhosis following mRNA COVID-19 vaccination.
    Al-Dury S; Waern J; Waldenström J; Alavanja M; Saed HH; Törnell A; Arabpour M; Wiktorin HG; Einarsdottir S; Ringlander J; Ringström G; Hellstrand K; Martner A; Lagging M
    JHEP Rep; 2022 Jul; 4(7):100496. PubMed ID: 35502229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of natural SARS-CoV-2 infection in seroprevalence studies among vaccinated populations.
    Demmer RT; Baumgartner B; Wiggen TD; Ulrich AK; Strickland AJ; Naumchik BM; Bohn B; Walsh S; Smith S; Kline S; Stovitz SD; Yendell S; Beebe T; Hedberg C
    medRxiv; 2021 Apr; ():. PubMed ID: 33907763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High unrecognized SARS-CoV-2 exposure of newly admitted and hospitalized psychiatric patients.
    El Abdellati K; Lucas A; Perron H; Tamouza R; Nkam I; Richard JR; Fried S; Barau C; Djonouma N; Pinot A; Fourati S; Rodriguez C; Coppens V; Meyer U; Morrens M; De Picker L; Leboyer M
    Brain Behav Immun; 2023 Nov; 114():500-510. PubMed ID: 37741299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination strategy and anti - SARS-CoV-2 S titers in healthcare workers of the INT - IRCCS "Fondazione Pascale" Cancer Center (Naples, Italy).
    Cavalcanti E; Isgrò MA; Rea D; Di Capua L; Trillò G; Russo L; Botti G; Miscio L; Buonaguro FM; Bianchi AAM
    Infect Agent Cancer; 2021 May; 16(1):32. PubMed ID: 33980271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals.
    Fraley E; LeMaster C; Geanes E; Banerjee D; Khanal S; Grundberg E; Selvarangan R; Bradley T
    BMC Med; 2021 Jul; 19(1):169. PubMed ID: 34304742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series.
    Danese E; Montagnana M; Salvagno GL; Peserico D; Pighi L; De Nitto S; Henry BM; Porru S; Lippi G
    Clin Chem Lab Med; 2021 Aug; 59(9):1585-1591. PubMed ID: 33838087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broad Cross-Reactive IgA and IgG against Human Coronaviruses in Milk Induced by COVID-19 Vaccination and Infection.
    Wang J; Young BE; Li D; Seppo A; Zhou Q; Wiltse A; Nowak-Wegrzyn A; Murphy K; Widrick K; Diaz N; Cruz-Vasquez J; M Järvinen K; Zand MS
    Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 antibody profile of naturally infected and vaccinated individuals detected using qualitative, semi-quantitative and multiplex immunoassays.
    Meyers J; Windau A; Schmotzer C; Saade E; Noguez J; Stempak L; Zhang X
    Diagn Microbiol Infect Dis; 2022 Dec; 104(4):115803. PubMed ID: 36162282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplex assessment of SARS-CoV-2 antibodies improves assay sensitivity and correlation with neutralizing antibodies.
    Cook N; Xu L; Hegazy S; Wheeler BJ; Anderson AR; Critelli N; Yost M; McElroy AK; Shurin MR; Wheeler SE
    Clin Biochem; 2021 Nov; 97():54-61. PubMed ID: 34453893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits.
    Ravichandran S; Coyle EM; Klenow L; Tang J; Grubbs G; Liu S; Wang T; Golding H; Khurana S
    Sci Transl Med; 2020 Jul; 12(550):. PubMed ID: 32513867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine.
    Lo Sasso B; Giglio RV; Vidali M; Scazzone C; Bivona G; Gambino CM; Ciaccio AM; Agnello L; Ciaccio M
    Diagnostics (Basel); 2021 Jun; 11(7):. PubMed ID: 34206567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Serological Profile and Specificity of Maternal and Neonatal Cord Blood SARS CoV-2 Antibodies.
    Boelig RC; Chaudhury S; Aghai ZH; Oliver E; Manusco F; Berghella V; Bergmann-Leitner E
    medRxiv; 2021 Dec; ():. PubMed ID: 34909795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in SARS-CoV-2 seroprevalence among pregnant women attending first antenatal care visits in Zambia: A repeated cross-sectional survey, 2021-2022.
    Heilmann E; Tembo T; Fwoloshi S; Kabamba B; Chilambe F; Kalenga K; Siwingwa M; Mulube C; Seffren V; Bolton-Moore C; Simwanza J; Yingst S; Yadav R; Rogier E; Auld AF; Agolory S; Kapina M; Gutman JR; Savory T; Kangale C; Mulenga LB; Sikazwe I; Hines JZ
    PLOS Glob Public Health; 2024; 4(4):e0003073. PubMed ID: 38568905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal analysis of SARS-CoV-2 infection and vaccination in the LA-SPARTA cohort reveals increased risk of infection in vaccinated Hispanic participants.
    Jenkins MM; Phan Tran D; Flores EA; Kupferwasser D; Pickering H; Zheng Y; Gjertson DW; Ross TM; Schaenman JM; Miller LG; Yeaman MR; Reed EF
    Front Immunol; 2023; 14():1139915. PubMed ID: 37153624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.